Request a copy

Full Text

• Rosenberg B, Van Camp L, Krigas T (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205:698-699
• Deconti RC, Toftness BR, Lange RC, Creasey WA (1973) Clinical and pharmacological studies with cis-diamminedichloroplatinum(II). Cancer Res 33:1310-1315
• Higby DJ, Wallace HJ, Albert DJ, Holland JF (1974) Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer 33:1219-1225
• Higby DJ, Wallace HJ, Holland JF (1973) Cis-diamminedichloroplatinum (NSC-119875): a phase I study. Cancer Chemother Rep 57:459-463
• Rozencweig M, Von Hoff DD, Slavik M, Muggia FM (1977) Cis-diamminedichloroplatinum (II). A new anticancer drug. Ann Intern Med 86:803-812
• Brayfield A (2007) Martindale: the complete drug reference. Pharmaceutical Press, London
• Lippert B (1999) Cisplatin: chemistry and biochemistry of a leading anticancer drug. Wiley, Basel. doi: 10.1002/9783906390420.ch10
• Kelland LR, Farrell NP (eds) (2000) Platinum-based drugs in cancer therapy. Humana Press Inc., Totowa
• Berger G, Gelbcke M, Cauët E et al (2013) Synthesis of 15N-labeled vicinal diamines through N-activated chiral aziridines: tools for the NMR study of platinum-based anticancer compounds. Tetrahedron Lett 54:545-548. doi: 10.1016/j.tetlet.2012.11.079
• Berger G, Gasper R, Lamoral-theys D et al (2010) Fourier transform infrared (FTIR) spectroscopy to monitor the cellular impact of newly synthesized platinum derivatives. Int J Oncol 37:679-686. doi: 10.3892/ijo
• Dufrasne F, Gelbcke M, Schnurr B, Gust R (2002) Synthesis and antitumor activity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)propane]dichloroplatinum(II) complexes. Arch Pharm (Weinheim) 335:229-239. doi: 10.1002/1521-4184(200205)335:5<229:AID-ARDP229>3.0.CO;2-Q
• Dullin A, Dufrasne F, Gelbcke M, Gust R (2004) Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines. Arch Pharm (Weinheim) 337:654-667. doi: 10.1002/ardp.200400621
• Dullin A, Dufrasne F, Gelbcke M, Gust R (2006) Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes. ChemMedChem 1:644-653. doi: 10.1002/cmdc.200600032
• Berger G, Leclercqz H, Derenne A et al (2014) Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: a fast method for new compound discovery. Bioorg Med Chem 22:3527-3536. doi: 10.1016/j.bmc.2014.04.017
• Brouwer J, van de Putte P, Fichtinger-Schepmant AMJ, Reedijk J (1981) Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II). Proc Natl Acad Sci 78:7010-7014
• Welters MJP, Fichtinger-schepman AMJ, Baan RA et al (1999) Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo. Br J Cancer 79:82-88
• Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99:2467-2498
• Bischin C, Lupan A, Taciuc V, Silaghi-dumitrescu R (2011) Interactions between proteins and platinum-containing anti-cancer drugs. Mini Rev Med Chem 11:214-224
• Casini A, Reedijk J (2012) Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry? Chem Sci 3:3135. doi: 10.1039/c2sc20627g
• Karasawa T, Sibrian-Vazquez M, Strongin RM, Steyger PS (2013) Identification of cisplatin-binding proteins using agarose conjugates of platinum compounds. PLoS One. doi: 10.1371/journal.pone.0066220
• Pinato O, Musetti C, Sissi C (2014) Pt-based drugs: the spotlight will be on proteins. Metallomics 6:380-395. doi: 10.1039/c3mt00357d
• Mezencev R (2015) Interactions of cisplatin with non-DNA targets and their influence on anticancer activity and drug toxicity: the complex world of the platinum complex. Curr Cancer Drug Targets 14:794-816
• Davis JT (2004) G-Quartets 40 years later: from 5'-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Ed Engl 43:668-698. doi: 10.1002/anie.200300589
• Watson JD, Crick FHC (1953) Molecular structure of nucleic acids. Nature 171:737-738
• Mergny J-L, Riou J-F, Mailliet P et al (2002) Natural and pharmacological regulation of telomerase. Nucleic Acids Res 30:839-865
• Kim NW, Piatyszek MA, Prowse KR et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015
• Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674. doi: 10.1016/j.cell.2011.02.013
• Parkinson GN, Lee MPH, Neidle S (2002) Crystal structure of parallel quadruplexes from human telomeric DNA. Nature 417:876-880. doi: 10.1038/nature755
• Wang Y, Patel DJ (1993) Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure 1:263-282
• Granotier C, Pennarun G, Riou L et al (2005) Preferential binding of a G-quadruplex ligand to human chromosome ends. Nucleic Acids Res 33:4182-4190. doi: 10.1093/nar/gki722
• Biffi G, Tannahill D, McCafferty J, Balasubramanian S (2013) Quantitative visualization of DNA G-quadruplex structures in human cells. Nat Chem 5:182-186. doi: 10.1038/nchem.1548
• Schaffitzel C, Berger I, Postberg J et al (2001) In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc Natl Acad Sci 98:8572-8577. doi: 10.1073/pnas.141229498
• Gellert M, Lipsett MN, Davies DR (1962) Helix formation by guanylic acid. Proc Natl Acad Sci 48:2013-2018
• Burger AM, Double JA, Newell DR (1997) Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur J Cancer 33:638-644. doi: 10.1016/S0959-8049(96)00521-7
• Ourliac-garnier I, Charif R, Bombard S (2009) Telomeres and telomerase: potential targets for platinum complexes. In: Hadjiliadis N, Sletten E (eds) Metal Complex-DNA Interactions. Wiley, pp 209-235
• Schwartz A, Sip M, Leng M (1990) Sodium cyanide: a chemical probe of the conformation of DNA modified by the antitumor drug cis-diamminedichloroplatinum(II). J Am Chem Soc 112:3673-3674. doi: 10.1021/ja00165a070
• Maxam AM, Gilbert W (1977) A new method for sequencing DNA. Proc Natl Acad Sci 74:560-564. doi: 10.1073/pnas.74.2.560
• Ourliac-Garnier I, Elizondo-Riojas M-A, Redon S et al (2005) Cross-links of quadruplex structures from human telomeric DNA by dinuclear platinum complexes show the flexibility of both structures. Biochemistry 44:10620-10634. doi: 10.1021/bi050144w
• Bertrand H, Bombard S, Monchaud D, Teulade-Fichou M-P (2007) A platinum-quinacridine hybrid as a G-quadruplex ligand. J Biol Inorg Chem 12:1003-1014. doi: 10.1007/s00775-007-0273-3
• Davies MS, Cox JW, Berners-Price SJ et al (2000) Equilibrium and kinetic studies of the aquation of the dinuclear platinum complex [[trans-PtCl(NH3)2]2(mu-NH2(CH2)6NH2)]2+: pKa determinations of aqua ligands via [1H,15N] NMR spectroscopy. Inorg Chem 39:1710-1715
• Cubo L, Thomas DS, Zhang J et al (2009) [1H,15N] NMR studies of the aquation of cis-diamine platinum(II) complexes. Inorg Chim Acta 362:1022-1026. doi: 10.1016/j.ica.2008.03.117
• Chai J-D, Head-Gordon M (2008) Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections. Phys Chem Chem Phys 10:6615-6620. doi: 10.1039/b810189b
• Dolg M, Cao X (2012) Relativistic pseudopotentials: their development and scope of applications. Chem Rev 112:403-480. doi: 10.1021/cr2001383
• Tomasi J, Mennucci B, Cammi R (2005) Quantum mechanical continuum solvation models. Chem Rev 105:2999-3093. doi: 10.1021/cr9904009
• Reed AE, Weinstock RB, Weinhold F (1985) Natural population analysis. J Chem Phys 83:735-746
• Szlachetko J, Nachtegaal M, de Boni E et al (2012) A von Hamos X-ray spectrometer based on a segmented-type diffraction crystal for single-shot X-ray emission spectroscopy and time-resolved resonant inelastic x-ray scattering studies. Rev Sci Instrum 83:103105
• Redon S, Bombard S, Elizondo-Riojas M-A, Chottard JC (2003) Platinum cross-linking of adenines and guanines on the quadruplex structures of the AG3(T2AG3)3 and (T2AG3)4 human telomere sequences in Na+ and K+ solutions. Nucleic Acids Res 31:1605-1613. doi: 10.1093/nar/gkg259
• Howe-Grant M, Lippard SJ (1980) Metallointercalation reagents: thiolato complexes of (2, 2′: 6′, 2′′-terpyridine)-platinum(II). Inorg Synth 20:101-105
• Berners-Price SJ, Ronconi L, Sadler PJ (2006) Insights into the mechanism of action of platinum anticancer drugs from multinuclear NMR spectroscopy. Prog Nucl Magn Reson Spectrosc 49:65-98. doi: 10.1016/j.pnmrs.2006.05.002
• Appleton TG, Hall JR, Ralph SF, Thompson CSM (1989) NMR of acid-base equilibria and other reactions of ammineplatinum complexes with aqua and hydroxo ligands. Inorg Chem 28:1989-1993
• Berners-Price SJ, Frenkiel TA, Frey U et al (1992) Hydrolysis products of cisplatin: pKa determinations via[1H, 15N] NMR spectroscopy. J Chem Soc, Chem Commun. doi: 10.1039/C39920000789
• Pearson RG (1963) Hard and soft acids and bases. J Am Chem Soc 85:3533-3539. doi: 10.1021/ja00905a001
• Parr RG, Yang W (1984) Density functional approach to the frontier-electron theory of chemical reactivity. J Am Chem Soc 106:4049-4050. doi: 10.1021/ja00326a036
• Parr RG, Szentpaly LV, Liu S (1999) Electrophilicity index. J Am Chem Soc 121:1922-1924. doi: 10.1021/cr040109f
• Chattaraj PK, Sarkar U, Roy DR (2006) Electrophilicity index. Chem Rev 106:2065-2091. doi: 10.1021/cr040109f
• Geerlings P, De Proft F, Langenaeker W (2003) Conceptual density functional theory. Chem Rev 103:1793-1873. doi: 10.1021/cr990029p
• Yang W, Mortier WJ (1986) The use of global and local molecular parameters for the analysis of the gas-phase basicity of amines. J Am Chem Soc 108:5708-5711. doi: 10.1021/ja00279a008
• Koopmans T (1934) Über die Zuordnung von Wellenfunktionen und Eigenwerten zu den Einzelnen Elektronen Eines Atoms. Physica 1:104-113. doi: 10.1016/S0031-8914(34)90011-2
• Gust R, Gelbcke M, Angemaier B et al (1997) The stereoselectivity of antitumor active [1,2-diamino-1-phenylpropane] dichloroplatinum(II) complexes. Inorg Chim Acta 264:145-160
• Simon M, Schmitt T (eds) (2013) Progress in resonant inelastic X-ray scattering. Elsevier, Amsterdam, pp 1-182
• Sa J, Szlachetko J, Kleymenov E et al (2013) Fine tuning of gold electronic structure by IRMOF post-synthetic modification. RSC Adv 3:12043-12048. doi: 10.1039/C3RA40970H
• Szlachetko J, Sá J, Nachtegaal M et al (2014) Real time determination of the electronic structure of unstable reaction intermediates during Au2O3 reduction. J Phys Chem Lett 5:80-84. doi: 10.1021/jz402309s
• Sa J, Kayser Y, Milne CJ et al (2014) Temperature-programmed reduction of NiO nanoparticles followed by time-resolved RIXS. Phys Chem Chem Phys 16:7692-7696. doi: 10.1039/C3CP54622E
• Hammer B, Norskov JK (1995) Why gold is the noblest of all the metals. Nature 376:238-240
• Bligaard T, Nørskov JK, Dahl S et al (2004) The Brønsted-Evans-Polanyi relation and the volcano curve in heterogeneous catalysis. J Catal 224:206-217. doi: 10.1016/j.jcat.2004.02.034
• Ankudinov AL, Rehr JJ, Conradson SD (1998) Real-space multiple-scattering calculation and interpretation of X-ray-absorption near-edge structure. Phys Rev B 58:7565-7576. doi: 10.1103/PhysRevB.58.7565
• Rehr JJ, Albers RC (2000) Theoretical approaches to X-ray absorption fine structure. Rev Mod Phys 72:621-654. doi: 10.1103/RevModPhys.72.621
• Ankudinov AL, Rehr JJ, Low J, Bare SR (2001) Effect of hydrogen adsorption on the X-ray absorption spectra of small Pt clusters. Phys Rev Lett 86:1642-1645. doi: 10.1103/PhysRevLett.86.1642
• Summa N, Schiessl W, Puchta R et al (2006) Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles. Inorg Chem 45:2948-2959. doi: 10.1021/ic051955r